Total planned funding: $58,086,255
Clear active filters
Multi-lateral Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Zambia | $8,139,811 |
| Mozambique | $6,187,500 |
| Eswatini | $5,929,130 |
| Asia Regional Program | $5,460,608 |
| South Africa | $5,191,233 |
| Uganda | $4,275,585 |
| Burma | $4,273,257 |
| Zimbabwe | $3,676,316 |
| Kenya | $2,621,514 |
| Tanzania | $2,018,352 |
| Malawi | $1,642,114 |
| Ethiopia | $1,437,724 |
| Ukraine | $1,300,000 |
| Namibia | $920,000 |
| India | $850,000 |
| enumerations.Philippines | $800,000 |
| Papua New Guinea | $600,000 |
| Nigeria | $500,000 |
| Rwanda | $495,261 |
| Côte d'Ivoire | $473,000 |
| Dominican Republic | $367,691 |
| Central America Region | $311,990 |
| Vietnam | $230,169 |
| Caribbean Region | $200,000 |
| Democratic Republic of the Congo | $125,000 |
| West Africa Region | $60,000 |
| Central Asia Region | $0 |
Organizational Types
| Multi-lateral Agency | $58,086,255 |
Program Areas
| Care | $24,770,613 |
| Treatment | $11,616,000 |
| Prevention | $9,875,233 |
| Governance and Systems | $9,666,879 |
| Testing | $2,157,530 |
Budget Codes
| HKID: Care: Orphans and Vulnerable Children | $16,247,707 |
| HTXS: Treatment: Adult Treatment | $11,374,982 |
| HBHC: Care: Adult Care and Support | $6,608,561 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $5,406,264 |
| HVSI: Strategic Information | $4,763,380 |
| OHSS: Health Systems Strengthening | $3,559,494 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,300,873 |
| HVCT: Testing: HIV Testing and Counseling | $2,157,530 |
| HVTB: Care: TB/HIV | $1,641,690 |
| HLAB: Laboratory Infrastructure | $1,344,005 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $1,219,564 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $578,054 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $370,478 |
| PDCS: Care: Pediatric Care and Support | $272,655 |
| PDTX: Treatment: Pediatric Treatment | $241,018 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |